These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2539000)

  • 1. The choice of treatment after incomplete adenomectomy in acromegaly: proton--versus high voltage radiation.
    Lüdecke DK; Lutz BS; Niedworok G
    Acta Neurochir (Wien); 1989; 96(1-2):32-8. PubMed ID: 2539000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion.
    Arosio M; Ambrosi B; Guglielmino L; Faglia G
    J Endocrinol Invest; 1985 Oct; 8(5):449-53. PubMed ID: 2867112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone response to oral glucose before and after transfrontal pituitary surgery and radiotherapy in acromegaly.
    Dash RJ; Saini JS; Chander S; Kak VK; Ayyagari S
    J Assoc Physicians India; 1986 Mar; 34(3):171-3. PubMed ID: 3015867
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma growth hormone half-life after selective removal of adenoma in acromegalics determines the outcome of surgery.
    Roelfsema F; van der Heide D; Lowry PJ; van Dulken H; Schröder-van der Elst J
    Clin Endocrinol (Oxf); 1988 Jan; 28(1):51-9. PubMed ID: 2844444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heavy-particle therapy for acromegaly, Cushing's disease, Nelson's syndrome, and nonfunctioning pituitary adenomas.
    Linfoot JA; Chong CY; Garcia JF; Cleveland AS; Connell GM; Manougian E; Okerlund MD; Born JL; Lawrence JH
    Prog At Med; 1971; 3():219-38. PubMed ID: 4335128
    [No Abstract]   [Full Text] [Related]  

  • 6. Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy.
    Serri O; Somma M; Comtois R; Rasio E; Beauregard H; Jilwan N; Hardy J
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1185-9. PubMed ID: 4055986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial plasma growth hormone concentration during selective removal of pituitary tumors in acromegaly.
    Allen JP; Cook DM; Greer MA; Paxton H; Castro A
    J Neurosurg; 1974 Jul; 41(1):38-43. PubMed ID: 4366356
    [No Abstract]   [Full Text] [Related]  

  • 8. Transsphenoidal microsurgery in the treatment of acromegaly and gigantism.
    Arafah BU; Brodkey JS; Kaufman B; Velasco M; Manni A; Pearson OH
    J Clin Endocrinol Metab; 1980 Mar; 50(3):578-85. PubMed ID: 6244327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of acromegaly].
    Quabbe HJ
    Dtsch Med Wochenschr; 1982 Jul; 107(27):1060-3. PubMed ID: 7084073
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of stereotactic radiosurgery in the multimodal management of growth hormone-secreting pituitary adenomas.
    Stapleton CJ; Liu CY; Weiss MH
    Neurosurg Focus; 2010 Oct; 29(4):E11. PubMed ID: 20887121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma.
    Lissett CA; Peacey SR; Laing I; Tetlow L; Davis JR; Shalet SM
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):653-7. PubMed ID: 10197082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure.
    Sheaves R; Jenkins P; Blackburn P; Huneidi AH; Afshar F; Medbak S; Grossman AB; Besser GM; Wass JA
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):407-13. PubMed ID: 8959078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endocrinologic evaluation of 61 patients with acromegaly treated with transsphenoidal removal alone, or associated with telecobalt irradiation or bromocriptine or both].
    Barceló B; Pérez C; Dávila N; Lucas T; Salto L; Alcañiz J
    Med Clin (Barc); 1983 May; 80(17):735-41. PubMed ID: 6621120
    [No Abstract]   [Full Text] [Related]  

  • 14. [The results of hypophyseal irradiation with a proton beam in acromegaly patients].
    Marova EI; Avakian MR; Kirpatovskaia LE; Saakian OA; Anisimov SI; Chepyga RV
    Probl Endokrinol (Mosk); 1990; 36(1):31-7. PubMed ID: 2158655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endocrine function in the late period after radiation therapy of acromegaly].
    Avakian MR; Marova EI; Kurpatovskaia LE
    Zh Vopr Neirokhir Im N N Burdenko; 1989; (5):32-4. PubMed ID: 2556879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors determining the long-term outcome of surgery for acromegaly.
    Osman IA; James RA; Chatterjee S; Mathias D; Kendall-Taylor P
    QJM; 1994 Oct; 87(10):617-23. PubMed ID: 7987657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent results of secondary transnasal surgery for residual or recurring acromegaly.
    Abe T; Lüdecke DK
    Neurosurgery; 1998 May; 42(5):1013-21; discussion 1021-2. PubMed ID: 9588545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience.
    Ahmed S; Elsheikh M; Stratton IM; Page RC; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 1999 May; 50(5):561-7. PubMed ID: 10468920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma knife radiosurgery for acromegaly--long-term experience.
    Jezková J; Marek J; Hána V; Krsek M; Weiss V; Vladyka V; Lisák R; Vymazal J; Pecen L
    Clin Endocrinol (Oxf); 2006 May; 64(5):588-95. PubMed ID: 16649981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure.
    Tindall GT; Oyesiku NM; Watts NB; Clark RV; Christy JH; Adams DA
    J Neurosurg; 1993 Feb; 78(2):205-15. PubMed ID: 8421204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.